Lappe Mark

US insider· US
Sign in for alerts
HoldingsTimelineOverlapsAbout
  • ACQUIREDT+30

    Inhibrx Biosciences Inc · NASDAQ

    +1,500 sh · $148.3K

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Inhibrx Biosciences Inc · NASDAQ

    +2,176 sh · $216.7K

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Inhibrx Biosciences Inc · NASDAQ

    +3,000 sh · $305.1K

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Inhibrx Biosciences Inc · NASDAQ

    +3,324 sh · $328.6K

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +1,100 sh · $117.8K

    Filed 8 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +5,895 sh · $585.3K

    Filed 8 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +9,681 sh · $1.1M

    Filed 8 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +500 sh · $54.1K

    Filed 8 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +6,605 sh · $664.7K

    Filed 8 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Inhibrx Biosciences Inc · NASDAQ

    +1,219 sh · $136.4K

    Filed 8 Sept 2026SEC Form 4view source